Journal of Chest Surgery

  • 제53권4호
  • /
  • Pages.152-159
  • /
  • 2020
  • /
  • 2765-1606(pISSN)
  • /
  • 2765-1614(eISSN)
대한심장혈관흉부외과학회 (The Korean Society for Thoracic and Cardiovascular Surgery)
권호 표지
DOI QR코드

DOI QR Code

Current Issues in Minimally Invasive Esophagectomy

  • Na, Kwon Joong (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Kang, Chang Hyun (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
  • 투고 : 2020.05.06
  • 심사 : 2020.05.25
  • 발행 : 2020.08.05
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Minimally invasive esophagectomy (MIE) was first introduced in the 1990s. Currently, it is a widely accepted surgical approach for the treatment of esophageal cancer, as it is an oncologically sound procedure; its advantages when compared to open procedures, including reduction in postoperative complications, reduction in the length of hospital stay, and improvement in quality of life, are well documented. However, debates are still ongoing about the safety and efficacy of MIE. The present review focuses on some of the current issues related to conventional MIE and robot-assisted MIE based on evidence from the current literature.

키워드

참고문헌

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424. https://doi.org/10.3322/caac.21492
  2. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Akinyemiju TF, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol 2018;4:1553-68. https://doi.org/10.1001/jamaoncol.2018.2706
  3. Alderson D, Cunningham D, Nankivell M, et al. Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial. Lancet Oncol 2017;18:1249-60. https://doi.org/10.1016/S1470-2045(17)30447-3
  4. Van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012;366:2074-84. https://doi.org/10.1056/NEJMoa1112088
  5. Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 2012;379:1887-92. https://doi.org/10.1016/S0140-6736(12)60516-9
  6. Mariette C, Markar SR, Dabakuyo-Yonli TS, et al. Hybrid minimally invasive esophagectomy for esophageal cancer. N Engl J Med 2019;380:152-62. https://doi.org/10.1056/NEJMoa1805101
  7. Van der Sluis PC, van der Horst S, May AM, et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial. Ann Surg 2019;269:621-30. https://doi.org/10.1097/sla.0000000000003031
  8. Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 1992;37:7-11.
  9. DePaula AL, Hashiba K, Ferreira EA, de Paula RA, Grecco E. Laparoscopic transhiatal esophagectomy with esophagogastroplasty. Surg Laparosc Endosc 1995;5:1-5.
  10. Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003;238:486-94. https://doi.org/10.1097/00000658-200310000-00004
  11. Horgan S, Berger RA, Elli EF, Espat NJ. Robotic-assisted minimally invasive transhiatal esophagectomy. Am Surg 2003;69:624-6.
  12. Kernstine KH, DeArmond DT, Karimi M, et al. The robotic, 2-stage, 3-field esophagolymphadenectomy. J Thorac Cardiovasc Surg 2004;127:1847-9. https://doi.org/10.1016/j.jtcvs.2004.02.014
  13. Gottlieb-Vedi E, Kauppila JH, Malietzis G, Nilsson M, Markar SR, Lagergren J. Long-term survival in esophageal cancer after minimally invasive compared to open esophagectomy: a systematic review and meta-analysis. Ann Surg 2019;270:1005-17. https://doi.org/10.1097/SLA.0000000000003252
  14. Watanabe M, Baba Y, Nagai Y, Baba H. Minimally invasive esophagectomy for esophageal cancer: an updated review. Surg Today 2013;43:237-44. https://doi.org/10.1007/s00595-012-0300-z
  15. Giugliano DN, Berger AC, Rosato EL, Palazzo F. Total minimally invasive esophagectomy for esophageal cancer: approaches and outcomes. Langenbecks Arch Surg 2016;401:747-56. https://doi.org/10.1007/s00423-016-1469-1
  16. Luketich JD, Pennathur A, Awais O, et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 2012;256:95-103. https://doi.org/10.1097/SLA.0b013e3182590603
  17. Briez N, Piessen G, Torres F, Lebuffe G, Triboulet JP, Mariette C. Effects of hybrid minimally invasive oesophagectomy on major postoperative pulmonary complications. Br J Surg 2012;99:1547-53. https://doi.org/10.1002/bjs.8931
  18. Rinieri P, Ouattara M, Brioude G, et al. Long-term outcome of open versus hybrid minimally invasive Ivor Lewis oesophagectomy: a propensity score matched study. Eur J Cardiothorac Surg 2017;51:223-9.
  19. Booka E, Tsubosa Y, Haneda R, Ishii K. Ability of laparoscopic gastric mobilization to prevent pulmonary complications after open thoracotomy or thoracoscopic esophagectomy for esophageal cancer: a systematic review and meta-analysis. World J Surg 2020;44:980-9. https://doi.org/10.1007/s00268-019-05272-9
  20. Sakamoto T, Fujiogi M, Matsui H, Fushimi K, Yasunaga H. Comparing perioperative mortality and morbidity of minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a nationwide retrospective analysis. Ann Surg 2019 Jul 25 [Epub]. https://doi.org/10.1097/SLA.0000000000003500.
  21. Yoshida N, Yamamoto H, Baba H, et al. Can minimally invasive esophagectomy replace open esophagectomy for esophageal cancer?: latest analysis of 24,233 esophagectomies from the Japanese national clinical database. Ann Surg 2020;272:118-24. https://doi.org/10.1097/SLA.0000000000003222
  22. Palanivelu C, Prakash A, Senthilkumar R, et al. Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position: experience of 130 patients. J Am Coll Surg 2006;203:7-16. https://doi.org/10.1016/j.jamcollsurg.2006.03.016
  23. Seesing MFJ, Goense L, Ruurda JP, Luyer MDP, Nieuwenhuijzen GAP, van Hillegersberg R. Minimally invasive esophagectomy: a propensity score-matched analysis of semiprone versus prone position. Surg Endosc 2018;32:2758-65. https://doi.org/10.1007/s00464-017-5975-1
  24. Orringer MB, Sloan H. Esophagectomy without thoracotomy. J Thorac Cardiovasc Surg 1978;76:643-54. https://doi.org/10.1016/S0022-5223(19)41012-X
  25. Parry K, Ruurda JP, van der Sluis PC, van Hillegersberg R. Current status of laparoscopic transhiatal esophagectomy for esophageal cancer patients: a systematic review of the literature. Dis Esophagus 2017;30:1-7.
  26. Parker M, Pfluke JM, Shaddix KK, Asbun HJ, Smith CD, Bowers SP. Video: transcervical videoscopic esophageal dissection in minimally invasive esophagectomy. Surg Endosc 2011;25:941-2. https://doi.org/10.1007/s00464-010-1253-1
  27. Yoshimura S, Mori K, Yamagata Y, et al. Quality of life after robot-assisted transmediastinal radical surgery for esophageal cancer. Surg Endosc 2018;32:2249-54. https://doi.org/10.1007/s00464-017-5918-x
  28. Mori K, Yamagata Y, Aikou S, et al. Short-term outcomes of robotic radical esophagectomy for esophageal cancer by a nontransthoracic approach compared with conventional transthoracic surgery. Dis Esophagus 2016;29:429-34. https://doi.org/10.1111/dote.12345
  29. Van Hillegersberg R, Boone J, Draaisma WA, Broeders IA, Giezeman MJ, Borel Rinkes IH. First experience with robot-assisted thoracoscopic esophagolymphadenectomy for esophageal cancer. Surg Endosc 2006;20:1435-9. https://doi.org/10.1007/s00464-005-0674-8
  30. Ruurda JP, Draaisma WA, van Hillegersberg R, et al. Robot-assisted endoscopic surgery: a four-year single-center experience. Dig Surg 2005;22:313-20. https://doi.org/10.1159/000088628
  31. Na KJ, Park S, Park IK, Kim YT, Kang CH. Outcomes after total robotic esophagectomy for esophageal cancer: a propensity-matched comparison with hybrid robotic esophagectomy. J Thorac Dis 2019;11:5310-20. https://doi.org/10.21037/jtd.2019.11.58
  32. Van Workum F, Stenstra MHBC, Berkelmans GHK, et al. Learning curve and associated morbidity of minimally invasive esophagectomy: a retrospective multicenter study. Ann Surg 2019;269:88-94. https://doi.org/10.1097/sla.0000000000002469
  33. Ramage L, Deguara J, Davies A, et al. Gastric tube necrosis following minimally invasive oesophagectomy is a learning curve issue. Ann R Coll Surg Engl 2013;95:329-34.
  34. Sihag S, Kosinski AS, Gaissert HA, Wright CD, Schipper PH. Minimally invasive versus open esophagectomy for esophageal cancer: a comparison of early surgical outcomes from the society of thoracic surgeons national database. Ann Thorac Surg 2016;101:1281-8. https://doi.org/10.1016/j.athoracsur.2015.09.095
  35. Takeuchi H, Miyata H, Ozawa S, et al. Comparison of short-term outcomes between open and minimally invasive esophagectomy for esophageal cancer using a nationwide database in Japan. Ann Surg Oncol 2017;24:1821-7. https://doi.org/10.1245/s10434-017-5808-4
  36. Seesing MFJ, Gisbertz SS, Goense L, et al. A propensity score matched analysis of open versus minimally invasive transthoracic esophagectomy in the Netherlands. Ann Surg 2017;266:839-46. https://doi.org/10.1097/SLA.0000000000002393
  37. Mamidanna R, Bottle A, Aylin P, Faiz O, Hanna GB. Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England: a population-based national study. Ann Surg 2012;255:197-203. https://doi.org/10.1097/SLA.0b013e31823e39fa
  38. Hernandez JM, Dimou F, Weber J, et al. Defining the learning curve for robotic-assisted esophagogastrectomy. J Gastrointest Surg 2013;17:1346-51. https://doi.org/10.1007/s11605-013-2225-2
  39. Van der Sluis PC, Ruurda JP, van der Horst S, Goense L, van Hillegersberg R. Learning curve for robot-assisted minimally invasive thoracoscopic esophagectomy: results from 312 cases. Ann Thorac Surg 2018;106:264-71. https://doi.org/10.1016/j.athoracsur.2018.01.038
  40. Park S, Hyun K, Lee HJ, Park IK, Kim YT, Kang CH. A study of the learning curve for robotic oesophagectomy for oesophageal cancer. Eur J Cardiothorac Surg 2018;53:862-70. https://doi.org/10.1093/ejcts/ezx440
  41. Gottlieb-Vedi E, Mackenzie H, van Workum F, et al. Surgeon volume and surgeon age in relation to proficiency gain curves for prognosis following surgery for esophageal cancer. Ann Surg Oncol 2019;26:497-505. https://doi.org/10.1245/s10434-018-6869-8
  42. Van Workum F, Fransen L, Luyer MD, Rosman C. Learning curves in minimally invasive esophagectomy. World J Gastroenterol 2018;24:4974-8. https://doi.org/10.3748/wjg.v24.i44.4974
  43. Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177-83. https://doi.org/10.1097/00000658-200208000-00005
  44. Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewert JR. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005;242:566-73. https://doi.org/10.1097/00000658-200510000-00012
  45. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364-72. https://doi.org/10.1097/00000658-199409000-00012
  46. Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg 2010;251:46-50. https://doi.org/10.1097/SLA.0b013e3181b2f6ee
  47. Kutup A, Nentwich MF, Bollschweiler E, Bogoevski D, Izbicki JR, Holscher AH. What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: transthoracic versus transhiatal esophagectomy. Ann Surg 2014;260:1016-22. https://doi.org/10.1097/SLA.0000000000000335
  48. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3. https://doi.org/10.1016/0016-5085(93)90420-h
  49. Hesketh PJ, Clapp RW, Doos WG, Spechler SJ. The increasing frequency of adenocarcinoma of the esophagus. Cancer 1989;64:526-30. https://doi.org/10.1002/1097-0142(19890715)64:2<526::AID-CNCR2820640228>3.0.CO;2-B
  50. Leers JM, DeMeester SR, Chan N, et al. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. J Thorac Cardiovasc Surg 2009;138:594-602. https://doi.org/10.1016/j.jtcvs.2009.05.039
  51. Parry K, Haverkamp L, Bruijnen RC, Siersema PD, Ruurda JP, van Hillegersberg R. Surgical treatment of adenocarcinomas of the gastro-esophageal junction. Ann Surg Oncol 2015;22:597-603. https://doi.org/10.1245/s10434-014-4047-1
  52. Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 2008;248:549-56. https://doi.org/10.1097/SLA.0b013e318188c474
  53. Nagpal K, Ahmed K, Vats A, et al. Is minimally invasive surgery beneficial in the management of esophageal cancer?: a meta-analysis. Surg Endosc 2010;24:1621-9. https://doi.org/10.1007/s00464-009-0822-7
  54. Dantoc M, Cox MR, Eslick GD. Evidence to support the use of minimally invasive esophagectomy for esophageal cancer: a meta-analysis. Arch Surg 2012;147:768-76. https://doi.org/10.1001/archsurg.2012.1326
  55. Sato F, Shimada Y, Li Z, et al. Paratracheal lymph node metastasis is associated with cervical lymph node metastasis in patients with thoracic esophageal squamous cell carcinoma. Ann Surg Oncol 2002;9:65-70. https://doi.org/10.1245/aso.2002.9.1.65
  56. Wu J, Chen QX, Zhou XM, Mao WM, Krasna MJ. Does recurrent laryngeal nerve lymph node metastasis really affect the prognosis in node-positive patients with squamous cell carcinoma of the middle thoracic esophagus? BMC Surg 2014;14:43. https://doi.org/10.1186/1471-2482-14-43
  57. Cuesta MA. Review of different approaches of the left recurrent laryngeal nerve area for lymphadenectomy during minimally invasive esophagectomy. J Thorac Dis 2019;11:S766-70. https://doi.org/10.21037/jtd.2019.02.36
  58. Kim DJ, Park SY, Lee S, Kim HI, Hyung WJ. Feasibility of a robot-assisted thoracoscopic lymphadenectomy along the recurrent laryngeal nerves in radical esophagectomy for esophageal squamous carcinoma. Surg Endosc 2014;28:1866-73. https://doi.org/10.1007/s00464-013-3406-5
  59. Motoyama S, Sato Y, Wakita A, et al. Extensive lymph node dissection around the left laryngeal nerve achieved with robot-assisted thoracoscopic esophagectomy. Anticancer Res 2019;39:1337-42. https://doi.org/10.21873/anticanres.13246
  60. Park S, Hwang Y, Lee HJ, Park IK, Kim YT, Kang CH. Comparison of robot-assisted esophagectomy and thoracoscopic esophagectomy in esophageal squamous cell carcinoma. J Thorac Dis 2016;8:2853-61. https://doi.org/10.21037/jtd.2016.10.39
  61. Mariette C, Markar S, Dabakuyo-Yonli TS, et al. Health-related quality of life following hybrid minimally invasive versus open esophagectomy for patients with esophageal cancer, analysis of a multicenter, open-label, randomized phase III controlled trial: the MIRO trial. Ann Surg 2020;271:1023-9. https://doi.org/10.1097/SLA.0000000000003559
  62. Warner S, Chang YH, Paripati H, et al. Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy. Ann Thorac Surg 2014;97:439-45. https://doi.org/10.1016/j.athoracsur.2013.09.042
  63. Spector R, Zheng Y, Yeap BY, et al. The 3-hole minimally invasive esophagectomy: a safe procedure following neoadjuvant chemotherapy and radiation. Semin Thorac Cardiovasc Surg 2015;27:205-15. https://doi.org/10.1053/j.semtcvs.2015.06.003
  64. Goense L, van Rossum PS, Ruurda JP, et al. Radiation to the gastric fundus increases the risk of anastomotic leakage after esophagectomy. Ann Thorac Surg 2016;102:1798-804. https://doi.org/10.1016/j.athoracsur.2016.08.027
  65. Straatman J, van der Wielen N, Cuesta MA, et al. Minimally Invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the TIME trial. Ann Surg 2017;266:232-6. https://doi.org/10.1097/SLA.0000000000002171
  66. Kataoka K, Takeuchi H, Mizusawa J, et al. A randomized phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409. Jpn J Clin Oncol 2016;46:174-7. https://doi.org/10.1093/jjco/hyv178

피인용 문헌

  1. Long-Term, Health-Related Quality of Life after Open and Robot-Assisted Ivor-Lewis Procedures—A Propensity Score-Matched Study vol.9, pp.11, 2020, https://doi.org/10.3390/jcm9113513